MBX-2982
Catalog No. A12634
MBX-2982是针对2型糖尿病的潜在一流疗法，其靶向G蛋白偶联受体119（GPR119），该受体与已知刺激葡萄糖依赖性胰岛素分泌的生物活性脂质相互作用。
| Catalog Num | A12634 |
|---|---|
| M. Wt | 448.54 |
| Formula | C22H24N8OS |
| Purity | >98% |
| Storage | at -20°C 3 years Powder |
| CAS No. | 1037792-44-1 |
| Synonyms | MBX2982 |
| SMILES | CCC1=CN=C(N=C1)N2CCC(CC2)C3=NC(=CS3)COC4=CC=C(C=C4)N5C=NN=N5 |
MBX-2982是针对2型糖尿病的潜在一流疗法，其靶向G蛋白偶联受体119（GPR119），该受体与已知刺激葡萄糖依赖性胰岛素分泌的生物活性脂质相互作用。
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.1 mM | 22.29 mL | 111.47 mL | 222.95 mL |
| 0.5 mM | 4.46 mL | 22.29 mL | 44.59 mL |
| 1 mM | 2.23 mL | 11.15 mL | 22.29 mL |
| 5 mM | 0.45 mL | 2.23 mL | 4.46 mL |
*The above data is based on the productmolecular weight 448.54. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
Contact information
United StatesAdooq Bioscience
Toll Free: (866) 930-6790
Fax: +1-323-606-8156
Email: sales@adooq.com
ADOOQ 产品质量保证
We promise all products to perform as described.